Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study

References

• Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80–86.
   PubMed Web of Science ®Google Scholar
• Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy—an inflammatory view. Trends Immunol 2006;27: 399–404.
   PubMed Web of Science ®Google Scholar
• Walker ID, Kujovich JL, Greer IA, Rey E, David M, Salmon JE, Hunt BJ, et al. The use of LMWH in pregnancies at risk: new evidence or perception? J Thromb Haemost 2005;3:778–793.
   PubMed Web of Science ®Google Scholar
• Gori AM, Attanasio M, Gazzini A, Rossi L, Lucarini L, Miletti S, Chini J, et al. Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. J Thromb Haemost 2004;2:1657–1662.
   PubMed Web of Science ®Google Scholar
• Hochart H, Jenkins PV, Smith OP, White B. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol 2006;133:62–67.
   PubMed Web of Science ®Google Scholar
• Paidas MJ, Ku DH, Langhoff-Roos J, Arkel YS. Inherited thrombophilias and adverse pregnancy outcome: screening and management. Semin Perinatol 2005;29:150–163.
   PubMed Web of Science ®Google Scholar
• Rodger MA, Paidas M, McLintock C, Claire M, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008;112:320–324.
   PubMed Web of Science ®Google Scholar
• Di Simone N, Di Nicuolo F, Sanguinetti M, Ferrazzani S, D’Alessio MC, Castellani R, Bompiani A, Caruso A. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta 2007; 28:298–304.
   PubMed Web of Science ®Google Scholar
• Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L, Huppertz B. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. Am J Obstet Gynecol 2005;192:23–30.
   PubMed Web of Science ®Google Scholar
• Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res 2010;125:e240–e245.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, Mannucci PM. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015–1018.
   PubMed Web of Science ®Google Scholar
• Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901–908.
   PubMed Web of Science ®Google Scholar
• Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009;7:58–64.
   PubMed Web of Science ®Google Scholar
• Gris JC, Chauleur C, Faillie JL, Baer G, Marès P, Fabbro-Peray P, Quéré I, et al. Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. Thromb Haemost 2010;104:771–779.
   PubMedGoogle Scholar
• Protocol: Trial of Umbilical and Fetal Flow in Europe (TRUFFLE). Randomized trial of timing of delivery in early preterm fetal growth restriction based on early and late fetal Doppler venous changes versus cardiotocography. Christoph Lees Study Co-ordinator (on behalf of the TRUFFLE multicentre group) Trial of umbilical and fetal flow in Europe (TRUFFLE): a multicentre randomised study. www.thelancet.com/protocol-reviews. Protocol 02PRT/34. NB The recruitment of this study had been closed on February 2011. The main outcome is neurological assessment at the age of 2.
   Google Scholar
• Marconi AM, Ronzoni S, Bozzetti P, Vailati S, Morabito A, Battaglia FC. Comparison of fetal and neonatal growth curves in detecting growth restriction. Obstet Gynecol 2008;112:1227–1234.
   PubMed Web of Science ®Google Scholar
• Todros T, Ferrazzi E, Groli C, Nicolini U, Parodi L, Pavoni M, Zorzoli A, Zucca S. Fitting growth curves to head and abdomen measurements of the fetus: a multicentric study. J Clin Ultrasound 1987;15:95–105.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of ischemic placental disease. Obstet Gynecol 2007;110:128–133.
   PubMed Web of Science ®Google Scholar
• Cathelain-Soland S, Coulon C, Subtil D, Houfflin-Debarge V, Deruelle P. [Subsequent pregnancy outcome in women with a history of preeclampsia and/or HELLP syndrome]. Gynecol Obstet Fertil 2010;38:166–172.
   PubMedGoogle Scholar
• Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol 2003;188:1504–1507; discussion 1507.
   PubMedGoogle Scholar
• Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol 2009;113:1217–1224.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–414.
   PubMed Web of Science ®Google Scholar
• Hossain N, Schatz F, Paidas MJ. Heparin and maternal fetal interface: why should it work to prevent pregnancy complications? Thromb Res 2009;124:653–655.
   PubMed Web of Science ®Google Scholar
• Paidas MJ. Thrombosis and regulation of the trophoblast at the maternal interface. Thromb Res 2009;124:387–388.
   PubMedGoogle Scholar
• Black M, Shetty A, Bhattacharya S. Obstetric outcomes subsequent to intrauterine death in the first pregnancy. BJOG 2008;115:269–274.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125–129.
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873–880.
   PubMed Web of Science ®Google Scholar
• Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 2010;117:314–320.
   PubMed Web of Science ®Google Scholar
• Wikström AK, Nash P, Eriksson UJ, Olovsson MH. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. Am J Obstet Gynecol 2009;201:597.e1–597.e8.
   Web of Science ®Google Scholar
• Cancello R, Clément K. Is obesity an inflammatory illness?Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006;113:1141–1147.
   PubMed Web of Science ®Google Scholar
• Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, Mandia L, et al. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011;32 Suppl:S4–S16.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408–1412.
   PubMed Web of Science ®Google Scholar
• van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006;195:723–728.
   PubMed Web of Science ®Google Scholar
• Martinelli I. Principal investigator. Multicentre, randomized, controller, open trial on efficacy of low molecular weight heparin in pregnant women with previous obstetrical complications. HAPPY Study” EUDRACT n°2006–004205. Sponsored by AIFA (Agenzia Italiana del Farmaco) NB The recruitment of this study had been closed on December 2010. Non yet any publicaiotn had appeared on the scientific literature.
   Google Scholar